B. Cakıcı Et Al. , "Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge," 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders. , vol.1, no.8, İstanbul, Turkey, pp.81-0, 2015
Cakıcı, B. Et Al. 2015. Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge. 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders. , (İstanbul, Turkey), 81-0.
Cakıcı, B., Aydın Cantürk, İ., Aydın, B., Candan, F., & Cabadak, H., (2015). Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge . 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders. (pp.81-0). İstanbul, Turkey
Cakıcı, Begum Et Al. "Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge," 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders., İstanbul, Turkey, 2015
Cakıcı, Begum Et Al. "Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge." 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders. , İstanbul, Turkey, pp.81-0, 2015
Cakıcı, B. Et Al. (2015) . "Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge." 1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders. , İstanbul, Turkey, pp.81-0.
@conferencepaper{conferencepaper, author={Begum Cakıcı Et Al. }, title={Association study of TRPM8 RS10166942 polymorphism in a Turkish Population with migranasinge}, congress name={1th Pharmacohenomics, increasing the safety and effectiveness of personalized therapy for metabolic disorders.}, city={İstanbul}, country={Turkey}, year={2015}, pages={81-0} }